: In September 2016, the American Academic of Pediatrics released a policy statement that adolescents with opioid use disorder should be offered pharmacotherapy with buprenorphine/naloxone, methadone, or naltrexone. In our clinical practice, however, we ha… (Source: SafetyLit) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your […]

Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to red… (Source: SafetyLit: All (Unduplicated)) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social […]

Five Points Wellness and Recovery: A 12-Month Bio-Psycho-Social Intensive Outpatient Treatment Program Utilizing Suboxone, Psychotherapy, Wellness and Occupational Support(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10419052.htm (Source: PRWeb: Medical Pharmaceuticals)

Feb. 25, 2013 — The United States Food and Drug Administration (FDA) has approved generic versions of Reckitt Benckiser Healthcare’s Suboxone sublingual tablets. Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg… (Source: Drugs.com – Pharma News)